Rachel Meighan-Mantha
Principal Analyst
USA
+24 year(s) experience
Rachel began her time at Citeline as a drug specialist, managing Trialtrove’s auxiliary drug database. Since then, she has worked as an analyst specializing in autoimmune/inflammation drugs, immuno-oncology/immunotherapy, pharmacogenomic biomarkers, companion diagnostics, repurposing of drugs and regulatory approval pathways.
Before joining us, Rachel was a scientist in genetic and molecular toxicology for a global contract research organization. She also worked as an adjunct professor at two community colleges and as a research fellow in vascular biology, pharmacology and cancer biology.
Medtech Insight: 世界の医療機器・医療技術の最新情報
11 Dec 2019
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Medtech Insight: 世界の医療機器・医療技術の最新情報
14 Feb 2019
The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.
Topic medtech
Medtech Insight: 世界の医療機器・医療技術の最新情報
22 Aug 2018
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
Topic Policy and regulation
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
22 Aug 2018
Johnson & Johnson's DePuy Synthes orthopedic business has taken a measured view of digital and robotic capabilities, rather than acquiring assets that perhaps do not fully meet its strategic needs. For the business's global R&D head Euan Thomson, any new technology must augment the group's abilities to drive meaningful outcomes.
Topic digital-health
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
08 Apr 2018
The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.
Topic digital-health
Medtech Insight: 世界の医療機器・医療技術の最新情報
By Ashley Yeo 21 Dec 2017
The Accelerated Access Review strikes most of the right notes, but there is still room for improvement.
Medtech Insight: 世界の医療機器・医療技術の最新情報
08 Dec 2017
The second Asian Medtech Associations Regulatory Networking discussion focused on a range of regional issues.
Medtech Insight: 世界の医療機器・医療技術の最新情報
24 Jul 2017
The pace of Brexit-related work that impacts the UK medtech industry shows no sign of slowing over the summer.
Topic Brexit
Medtech Insight: 世界の...
20 Feb 2020
Medtech Insight: 世界の...
19 Feb 2020
In Vivo: 医療用医薬品・医療機器...
10 Feb 2020
Medtech Insight: 世界の...
07 Feb 2020
In Vivo: 医療用医薬品・医療機器...
22 Jan 2020
Medtech Insight: 世界の...
11 Dec 2019
In Vivo: 医療用医薬品・医療機器...
10 Dec 2019
Medtech Insight: 世界の...
30 Oct 2019
Medtech Insight: 世界の...
21 Oct 2019
Medtech Insight: 世界の...
20 Sep 2019
Medtech Insight: 世界の...
20 Sep 2019
In Vivo: 医療用医薬品・医療機器...
11 Sep 2019
Medtech Insight: 世界の...
06 Sep 2019
Medtech Insight: 世界の...
22 Aug 2019
Medtech Insight: 世界の...
14 Aug 2019